Status:

UNKNOWN

Platelet and Red Blood Cell Volume Indices as Inflammatory Biomarkers in Ankylosing Spondylitis

Lead Sponsor:

Sohag University

Conditions:

Ankylosing Spondylitis

Eligibility:

All Genders

18-70 years

Brief Summary

this study aims to determine the relatioships among the NLR ,PLR ,MLR ,red cell volume and platelet volume indices levels as biomarkers in ankylosing spondylitis.

Eligibility Criteria

Inclusion

  • PATIENT WITH DISEASE DURATION OF MORE THAN 6 MONTHS
  • AGE MORE THAN 18 YEARS

Exclusion

  • PATIENT WITH CARDIAC ,CEREBROVASCULAR AND HEMATOLOGIC DIEASE
  • PTIENT WITH HYPERTENSION ,DIABETES ,METABOLIS SYNDROMES AND OTHER AUTOIMMUNE RHEUMATIC DISEASES.

Key Trial Info

Start Date :

August 1 2023

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

February 1 2024

Estimated Enrollment :

70 Patients enrolled

Trial Details

Trial ID

NCT05997108

Start Date

August 1 2023

End Date

February 1 2024

Last Update

August 18 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Sohag university Hospital

Sohag, Egypt

Platelet and Red Blood Cell Volume Indices as Inflammatory Biomarkers in Ankylosing Spondylitis | DecenTrialz